MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

Home > Insights into how the Fanconi Anaemia core complex activates DNA repair

Insights into how the Fanconi Anaemia core complex activates DNA repair

Insights into how the Fanconi Anaemia core complex activates DNA repair

Published on

Research carried out by Eeson Rajendra from Lori Passmore’s group in the LMB’s Structural Studies Division, in close collaboration with KJ Patel from the LMB’s PNAC Division, has brought together LMB expertise in protein biochemistry and genetics to study the disease Fanconi Anaemia (FA). For the first time, they have isolated the intact FA core […]

Novel lipid kinase structure lays the foundation for a new class of drugs

Published on

A collaboration between Roger Williams’ group here in the LMB’s Protein and Nucleic Acid Chemistry Division and Kevan Shokat’s group at the University of California, San Francisco has provided insight into potential targets for the design of a new class of anti-viral drugs. Enteroviruses cause diseases including polio; hand, foot and mouth disease and the […]

Nobel prize winning Cambridge scientist Max Perutz given new stamp of approval

Published on

The LMB’s founder, Max Perutz, who was honoured on the centenary of his birth with a Royal Mail Stamp, has now also had a postmark created for the occasion, which will appear on letters and parcels delivered around Cambridge this week. This article is no longer available from the source website: Cambridge News 20 May […]

LMB and AstraZeneca announce plan to launch joint research fund

Published on

The MRC Laboratory of Molecular Biology and AstraZeneca are today announcing a plan for a research fund to facilitate collaboration between LMB and AstraZeneca and MedImmune.  The fund will support a range of pre-clinical research projects aimed at better understanding fundamental biology and disease. Under the planned collaboration, the MRC LMB and AstraZeneca would also […]